LAUREN KILCREASE: Open Payments
NPI 1619200359 · TROY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 14 payments from 8 companies in 2025. Trend: 2023 $89 · 2024 $58 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $55 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Novo Nordisk Inc | 2 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Abbott Laboratories | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $16 |
Products named: Kerendia, JARDIANCE, VOQUEZNA, AIRSUPRA, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, INSPIRE, MOUNJARO.
Industry payments across AL — which companies pay providers there.
